June 9, 2010 10:08 AM
- Text
Common Pain Relievers Linked to Heart Deaths
(CBS)
For the first time, some commonly-used pain relievers have been linked by significant clinical evidence to a higher risk of heart-related deaths in otherwise healthy people.
The nine-year Danish study looked at non-steroidal anti-inflammatory drugs, including ibuprofen, which was associated with a 29 percent greater risk of fatal or non-fatal stroke.
The group of drugs examined is known as NSAIDs, which are commonly prescribed to people suffering from arthritis or inflammation due to short-term conditions.
The study, published in the American Heart Association's journal, "Cardiovascular Quality and Outcomes," focused on the drugs ibuprofen, diclofenac, rofecoxib, celecoxib and naproxen.
Study authors said they had been unable to determine the risks of celecoxib based on the results of their research. Naproxen - sold over the counter under brand names including "Alleve," was actually linked to a decreased risk in heart failures.
"Even though the frequency of these effects is quite low, they are still important," said Emil Loldrup Fosbøl, the study's author. "People should at a minimum be aware that this is a problem."
For individuals taking NSAIDs who are at a greater risk of stroke, the American Heart Association's advice is "a stepped-care approach to pain management," which recommends doctors only opt for the higher-risk medications after first demonstrating lower-risk drugs are ineffective.
The study reinforces advice given by the American Heart Association (AHA) in 2007 which advised doctors of a link between NSAIDs and heart failure.
"I find this new study reassuring because it endorses the recommendations we made using a large body of actual clinical evidence," said Elliott M. Antman, a professor at Harvard Medical School and Brigham and Women's Hospital in Boston who wrote the AHA statement.
"Doses examined in this new study were very similar to doses that patients are likely to encounter both at the over-the-counter level (OTC) and the prescription level," added Antman. "For patients regularly taking an NSAID now - whether it's a prescription or OTC - it is advisable to discuss with your physician why it was originally recommended or prescribed, whether you need to continue taking it, and at what dose."
The nine-year Danish study looked at non-steroidal anti-inflammatory drugs, including ibuprofen, which was associated with a 29 percent greater risk of fatal or non-fatal stroke.
The group of drugs examined is known as NSAIDs, which are commonly prescribed to people suffering from arthritis or inflammation due to short-term conditions.
The study, published in the American Heart Association's journal, "Cardiovascular Quality and Outcomes," focused on the drugs ibuprofen, diclofenac, rofecoxib, celecoxib and naproxen.
Study authors said they had been unable to determine the risks of celecoxib based on the results of their research. Naproxen - sold over the counter under brand names including "Alleve," was actually linked to a decreased risk in heart failures.
"Even though the frequency of these effects is quite low, they are still important," said Emil Loldrup Fosbøl, the study's author. "People should at a minimum be aware that this is a problem."
For individuals taking NSAIDs who are at a greater risk of stroke, the American Heart Association's advice is "a stepped-care approach to pain management," which recommends doctors only opt for the higher-risk medications after first demonstrating lower-risk drugs are ineffective.
The study reinforces advice given by the American Heart Association (AHA) in 2007 which advised doctors of a link between NSAIDs and heart failure.
"I find this new study reassuring because it endorses the recommendations we made using a large body of actual clinical evidence," said Elliott M. Antman, a professor at Harvard Medical School and Brigham and Women's Hospital in Boston who wrote the AHA statement.
"Doses examined in this new study were very similar to doses that patients are likely to encounter both at the over-the-counter level (OTC) and the prescription level," added Antman. "For patients regularly taking an NSAID now - whether it's a prescription or OTC - it is advisable to discuss with your physician why it was originally recommended or prescribed, whether you need to continue taking it, and at what dose."
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Norovirus outbreak hits Rider University in N.J
- Marijuana-smoking motorists twice as likely to crash
- Electric shocks to brain may boost memory: Study
- Chinese mom gives birth to 15-pound baby
- America's pets also have an obesity epidemic
- Measles patient at Super Bowl prompts health alert
- America's sodium problem: Not from salty snacks?
- Caffeine inhalers - the next club drug?
- Skin cancer self-exam: What to look for (PHOTOS)
- 4.5 million Americans over 50 have artificial knees
- Things You Didn't Know About Your Penis
- PICTURES: 15 Shocking Sexual Fetishes
- Let's Move! campaign turns 2 today: Is it working?
- Drinking soda raises risk for asthma, COPD: Study
- Christina Hendricks: Too Big for Hollywood?
- Woman spotlights uterus didelphys on talk show
Latest CBS News Headlines
on Facebook
on CBS News
- List of World Press Photo winners
- List of World Press Photo winners
- Arab Spring shot wins World Press Photo award
- Painter William Theophilus Brown dies at age 92
on Facebook
- Adele sings a cappella for Anderson Cooper
- Adele sings a cappella for Anderson Cooper
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






